With a strong foundation in finance and entrepreneurship, Nick Romay has carved out a significant presence as an innovative investor-operator. His career includes notable engagements across various sectors, where he has demonstrated expertise in driving growth and operational efficiencies. Known for his strategic insights, he actively participates in high-impact ventures that seek to enhance market value through transformational leadership. By blending financial acumen with hands-on management experience, Romay has positioned himself as a key player within the capital markets landscape.
With a strong foundation in finance and entrepreneurship, Nick Romay has carved out a significant presence as an innovative investor-operator. His career includes notable engagements across various sectors, where he has demonstrated expertise in driving growth and operational efficiencies. Known for his strategic insights, he actively participates in high-impact ventures that seek to enhance market value through transformational leadership. By blending financial acumen with hands-on management experience, Romay has positioned himself as a key player within the capital markets landscape.
Innovation plays a pivotal role in shaping investment strategies, and Nick Romay exemplifies this dynamic approach. Leveraging an entrepreneurial background, he pursues opportunities that marry operational efficiency with market expansion potential. By focusing on transformative business models and scalable ventures, he identifies compelling value propositions within various sectors. His strategic thinking enables him to navigate complex challenges while fostering sustainable growth. This forward-thinking mindset is complemented by a commitment to enhancing company performance through effective leadership, ensuring his investments generate significant returns while making a lasting impact.
Innovation plays a pivotal role in shaping investment strategies, and Nick Romay exemplifies this dynamic approach. Leveraging an entrepreneurial background, he pursues opportunities that marry operational efficiency with market expansion potential. By focusing on transformative business models and scalable ventures, he identifies compelling value propositions within various sectors. His strategic thinking enables him to navigate complex challenges while fostering sustainable growth. This forward-thinking mindset is complemented by a commitment to enhancing company performance through effective leadership, ensuring his investments generate significant returns while making a lasting impact.
| Trades 1268 | Longs Won 766/1268 60% | Profit Factor 5 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $135,401.3 |
| Average Win $58,251.04 | Best Trade (Oct 22) $2.92M | Sharpe Ratio -10.01 |
| Average Loss -$17,760.5 | Worst Trade (Jun 29) -$428,652.11 | Z-Score 3.41 (99.93%) |
| Commissions $0 | Avg. Trade Length 9m 1w 5d | Expectancy $25,655.83 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 12,346 | 11,111 | 9,877 | 8,642 | 7,407 | 6,173 | 4,938 | 3,704 | 2,469 | 1,235 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 14,665 | $3.52M | $5.08M | - | $1.56M | 44.44% | -0.48% |
ABBV AbbVie Inc. | 2,538 | $493,888.15 | $725,893.38 | - | $232,005.23 | 46.98% | +0.288% |
ACWI iShares MSCI ACWI ETF | 8,754 | $1.03M | $1.37M | - | $345,332.03 | 33.57% | -0.292% |
ADCT ADC Therapeutics SA | 23,768 | $74,180.68 | $35,295.48 | - | -$38,885.2 | -52.42% | -7.188% |
AEE Ameren Corporation | 4,419 | $424,947.4 | $475,793.73 | - | $50,846.33 | 11.97% | -1.166% |
AHR American Healthcare REIT, Inc. | 5,725 | $246,601.18 | $301,192.25 | - | $54,591.07 | 22.14% | -1.479% |
AMAT Applied Materials Inc. | 300 | $216,835 | $114,051 | - | -$102,784 | -47.4% | +1.222% |
AMD Advanced Micro Devices Inc. | 1,698 | $273,777.26 | $880,429.98 | - | $606,652.72 | 221.59% | +2.083% |
AMGN Amgen Inc. Common Stock | 625 | $219,847.66 | $275,525 | - | $55,677.34 | 25.33% | -1.44% |
AMZN Amazon.com Inc | 9,158 | $1.79M | $2.28M | - | $485,977.67 | 27.08% | -0.547% |
AOA iShares Core 80/20 Aggressive Allocation ETF | 8,622 | $728,695.25 | $831,290.13 | - | $102,594.88 | 14.08% | -0.336% |
AOR iShares Core 60/40 Balanced Allocation ETF | 6,107 | $397,226.54 | $416,283.65 | - | $19,057.11 | 4.8% | -0.285% |
ASML ASML Holding N.V. NY Registered Shares | 120 | $238,733 | $189,060 | - | -$49,673 | -20.81% | +0.959% |
AVEM Avantis Emerging Markets Equity ETF | 4,507 | $338,559.06 | $394,159.68 | - | $55,600.62 | 16.42% | +0.246% |
AVGO Broadcom Inc. | 5,416 | $1.03M | $1.76M | - | $727,236.5 | 70.38% | +0.566% |
AVUS Avantis U.S. Equity ETF | 4,500 | $489,149.82 | $577,147.5 | - | $87,997.68 | 17.99% | -0.415% |
AWK American Water Works Company, Inc. | 6,440 | $939,993.59 | $917,313.6 | - | -$22,679.99 | -2.41% | -0.552% |
AXP American Express Company | 872 | $245,065.19 | $273,193.24 | - | $28,128.05 | 11.48% | -3.652% |
AZN AstraZeneca PLC American Depositary Shares | 1,275 | $246,952 | $218,056.87 | - | -$28,895.13 | -11.7% | -0.895% |
BA The Boeing Company | 2,030 | $427,750.51 | $382,391.1 | - | -$45,359.41 | -10.6% | +0.437% |